Home - Products - Others - Other Targets - Cholecystokinin Octapeptide free acid (desulfated)

Cholecystokinin Octapeptide free acid (desulfated)

CAS No. ———

Cholecystokinin Octapeptide free acid (desulfated)( ——— )

Catalog No. M41018 CAS No. ———

Cholecystokinin Octapeptide free acid (desulfated)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cholecystokinin Octapeptide free acid (desulfated)
  • Note
    Research use only, not for human use.
  • Brief Description
    Cholecystokinin Octapeptide free acid (desulfated)
  • Description
    Cholecystokinin Octapeptide free acid (desulfated)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    1064.21
  • Molecular Formula
    C49H61N9O13S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CHR-6494 TFA

    CHR-6494 TFA is a potent haspin inhibitor, with an?IC50?of 2 nM. It inhibits histone H3T3 phosphorylation. CHR-6494 TFA induces the?apoptosis?of cancer cells, including melanoma and breast cancer. CHR-6494 TFA can be used in the research of cancer.

  • Kisspeptin 10 (dog)

    Endogenous ligand for the canine KISS1 receptor (Kisspeptin receptor or GPR54). Stimulates section of luteinizing hormone, follicle stimulating hormone and estradiol in vivo.

  • Fresolimumab

    Fresolimumab (GC1008) is a specific human anti-transforming growth factor β monoclonal antibody that binds to the active forms of human TGFβ1, TGFβ2, and TGFβ3 and can be used to study focal segmental glomerulosclerosis and cancer in adults.